O
CEMP

OrbiMed’s Cempra, Inc. CEMP Stock Holding History

OrbiMed’s Portfolio CEMP Stock Details CEMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,000
Closed -$1.72M – 148
2015
Q2 		$1.72M Hold
50,000
– – 0.01% 131
2015
Q1 		$1.72M Hold
50,000
– – 0.01% 130
2014
Q4 		$1.18M Buy
+50,000
New +$747K 0.01% 126

Other funds holding CEMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed's CEMP Position: Q3 2015 in Review

OrbiMed sold out of Cempra, Inc. (CEMP) in Q3 2015, closing a stake of 50,000 shares — an estimated $1.72M sold.

OrbiMed first reported a position in CEMP in Q4 2014 and held it in 3 quarters. The position peaked at $1.72M in Q2 2015. 151 funds tracked by Wall St. Rank hold CEMP as of Q3 2015.

  • OrbiMed reported no remaining Cempra, Inc. position as of Q3 2015 after selling out during the quarter.
  • OrbiMed sold 50,000 Cempra, Inc. shares in Q3 2015, an estimated $1.72M.
  • OrbiMed first reported a position in Cempra, Inc. in Q4 2014 and held it in 3 quarters.
  • OrbiMed's Cempra, Inc. position peaked at $1.72M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Cempra, Inc. as of Q3 2015.

Based on OrbiMed's 13F filing for Q3 2015, filed 13 Nov 2015.